Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSMA PET/CT”

215 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 215 results

Very early researchUnknownNCT02691169
What this trial is testing

Integrated 18F-labelled PSMA Project

Who this might be right for
Prostate Cancer
St. Joseph's Healthcare Hamilton 10
Early research (Phase 1)Looking for participantsNCT06062745
What this trial is testing

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma
Brigham and Women's Hospital 30
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Very early researchUnknownNCT05955677
What this trial is testing

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 100
Not applicableUnknownNCT06677775
What this trial is testing

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 30
Not applicableNot Yet RecruitingNCT07709403
What this trial is testing

Radioactive Counts From PSMA PET/CT-Targeted Biopsy Specimens for Real-time Diagnosis of Prostate Cancer: A Prospective Study

Who this might be right for
Prostate Cancer
Peking University First Hospital 20
Not applicableLooking for participantsNCT07707232
What this trial is testing

Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Wenzhou Medical University 4,600
Testing effectiveness (Phase 2)Study completedNCT06907641
What this trial is testing

Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy

Who this might be right for
Prostate Cancer (Post Prostatectomy)
St Vincent's Hospital, Sydney 50
Not applicableLooking for participantsNCT06450548
What this trial is testing

Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA

Who this might be right for
Prostate Cancer Metastatic
Centre Henri Becquerel 60
Not applicableUnknownNCT06054789
What this trial is testing

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

Who this might be right for
Prostate Cancer
Nanjing First Hospital, Nanjing Medical University 8
Very early researchStudy completedNCT04310540
What this trial is testing

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Mayo Clinic 42
Testing effectiveness (Phase 2)Looking for participantsNCT04573231
What this trial is testing

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 13
Testing effectiveness (Phase 2)Study completedNCT03454750
What this trial is testing

Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer68Ga-PSMA PET/CT Positive
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 143
Testing effectiveness (Phase 2)Ended earlyNCT05009979
What this trial is testing

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03471650
What this trial is testing

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 150
Not applicableStudy completedNCT05896449
What this trial is testing

Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin

Who this might be right for
Glioma, MalignantGlioma Glioblastoma Multiforme
Medical University of Warsaw 49
Not applicableNot Yet RecruitingNCT06298838
What this trial is testing

High-resolution Intra-operative PSMA PET-CT in Prostate Cancer

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 10
Not applicableUnknownNCT03134261
What this trial is testing

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

Who this might be right for
Prostate Cancer Metastatic to Bone
Herlev Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT05893381
What this trial is testing

Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)

Who this might be right for
Prostate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 70
Not applicableStudy completedNCT05079828
What this trial is testing

Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007

Who this might be right for
Prostate Cancer
Insel Gruppe AG, University Hospital Bern 100
Next Page